Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)

OBJECTIVE: Behavioral and psychological symptoms of dementia (BPSD) are associated with poorer prognosis of dementia. A 24-week study demonstrated that sodium benzoate, a D-amino acid oxidase (DAAO) inhibitor, surpassed placebo in improving cognitive function in early-phase Alzheimer’s disease; howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chieh-Hsin, Yang, Hui-Ting, Chen, Ping-Kun, Wang, Shi-Heng, Lane, Hsien-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039065/
https://www.ncbi.nlm.nih.gov/pubmed/32110025
http://dx.doi.org/10.2147/NDT.S234371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039065/
https://www.ncbi.nlm.nih.gov/pubmed/32110025
http://dx.doi.org/10.2147/NDT.S234371

Ejemplares similares